Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Thrombocytopenia 14Leukemia, Myeloid, Acute 5Leukemia 3Jacobs syndrome 3Myelodysplastic Syndromes 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Lymphocytic, Chronic, B-Cell 2Sarcoma 1Recurrence 1Purpura, Thrombocytopenic, Idiopathic 1Primary Myelofibrosis 1Pathologic Complete Response 1Myeloproliferative Disorders 1Multiple Myeloma 1Lymphoma, Mantle-Cell 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myeloid, Accelerated Phase 1Chemotherapy-induced Thrombocytopenia 1Blast Crisis 1Anemia, Refractory, with Excess of Blasts 1Anemia 1

Interventions

romiplostim 1oprelvekin 1hetrombopag 1eltrombopag 1avatrombopag 1Interleukin-11 1Injections 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Chemotherapy-induced Thrombocytopenia × eltrombopag × Classical hematology × Clear all
NCT04600960 2025-02-24

Eltrombopag for Chemotherapy-induced Thrombocytopenia

Institute of Hematology & Blood Diseases Hospital, China

Phase 2 Recruiting
50 enrolled
Classical hematology

Chemotherapy-induced Thrombocytopenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡